PROM1 and neoplasm: For example, studies in pancreatic cancer identified a slow-cycling population, enriched for the CSC markers CD24+/CD44+, CD133+ and ALDH, which also had enhanced chemotherapeutic resistance and could recreate the initial heterogeneous tumor cell population 18.